Complete Filing Data
BioNTech SE reported Cash And Cash Equivalents of $7.68 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean BioNTech SE did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Sales And Marketing Expense | $110.0M | $67.9M | $62.7M | $59.5M | $50.4M | $14.5M | $2.7M | $3.0M | $6.6M |
| Revenue From Contracts With Customers | $2.87B | $2.75B | $3.82B | $17.31B | $18.98B | $482.3M | $108.6M | $127.6M | $61.6M |
| Research And Development Expense | $2.10B | $2.25B | $1.78B | $1.54B | $949.2M | $645.0M | $226.5M | $143.0M | $85.5M |
| Profit Loss From Operating Activities | -$1.40B | -$1.31B | $690.4M | $12.64B | $15.28B | -$82.4M | -$181.5M | -$53.9M | -$61.3M |
| Profit Loss Before Tax | -$1.05B | -$677.7M | $1.19B | $12.95B | $15.05B | -$145.8M | -$179.4M | -$47.7M | -$85.9M |
| Profit Loss | -$1.14B | -$665.3M | $930.3M | $9.43B | $10.29B | $15.2M | -$179.2M | -$48.3M | -$86.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax | -$99.3M | $43.5M | -$19.8M | $11.2M | $8.4M | -$11.1M | $100.0K | $10.0K | -$23.0K |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | -$99.3M | $43.5M | -$19.8M | $11.2M | $8.4M | -$11.1M | $100.0K | $10.0K | -$23.0K |
| Other Comprehensive Income | -$114.8M | -$103.1M | -$15.8M | $22.3M | $8.7M | -$11.4M | $100.0K | $10.0K | -$23.0K |
| Income Taxes Paid Refund Classified As Operating Activities | -$3.8M | $389.2M | $482.9M | $4.22B | $3.46B | -$500.0K | -$200.0K | $304.0K | $45.0K |
| Income Tax Expense Continuing Operations | $85.3M | -$12.4M | $255.8M | $3.52B | $4.75B | -$161.0M | -$200.0K | $600.0K | $45.0K |
| General And Administrative Expense | $514.4M | $531.1M | $495.0M | $481.7M | $276.8M | $94.0M | $45.5M | $26.3M | $23.5M |
| Cost Of Sales | $641.8M | $541.3M | $599.8M | $3.00B | $2.91B | $59.3M | $17.4M | $13.7M | $9.3M |
| Comprehensive Income | -$1.25B | -$768.4M | $914.5M | $9.46B | $10.30B | $3.8M | -$179.1M | -$48.3M | -$86.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net Of Tax | -$15.5M | -$146.6M | $4.0M | $11.1M | $300.0K | -$300.0K | $0.00 | ||
| Other Comprehensive Income Net Of Tax Gains Losses On Remeasurements Of Defined Benefit Plans | $400.0K | $0.00 | $300.0K | $600.0K | $300.0K | -$300.0K | $0.00 | ||
| Profit Loss Attributable To Owners Of Parent | -$1.14B | -$665.3M | $930.3M | $10.29B | $15.2M | -$179.1M | -$48.0M | -$85.7M | |
| Comprehensive Income Attributable To Owners Of Parent | $10.30B | $3.8M | -$179.0M | -$48.0M | -$85.7M | ||||
| Profit Loss Attributable To Noncontrolling Interests | $0.00 | $0.00 | -$100.0K | -$243.0K | -$297.0K | ||||
| Comprehensive Income Attributable To Noncontrolling Interests | $0.00 | $0.00 | -$100.0K | -$243.0K | -$297.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $7.68B | $9.76B | $11.66B | $13.88B | $1.69B | $1.21B | $519.1M | $411.5M | $172.1M | $303.7M |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $175.1M | $286.5M | $249.4M | $329.2M | $127.5M | $66.0M | $38.6M | $29.9M | $24.3M | |
| Cash Flows From Used In Operating Activities | $456.0M | $207.7M | $5.37B | $13.58B | $889.7M | -$13.5M | -$198.5M | -$58.9M | -$52.6M | |
| Cash Flows From Used In Investing Activities | -$2.47B | -$2.08B | -$6.95B | -$35.3M | -$566.1M | -$144.8M | -$77.2M | -$66.5M | -$52.5M | |
| Cash Flows From Used In Financing Activities | -$52.9M | -$45.9M | -$778.6M | -$1.42B | $94.2M | $894.7M | $383.3M | $365.2M | -$1.6M | |
| Adjustments For Gain Loss On Disposals Property Plant And Equipment | $2.5M | $300.0K | -$3.8M | -$600.0K | -$4.6M | -$600.0K | -$500.0K | $14.0K | -$15.0K | |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | -$186.3M | $0.00 | $336.9M | $0.00 | $20.8M | $60.6M | $6.1M | |||
| Property Plant And Equipment | $1.08B | $935.3M | $757.2M | $609.2M | $322.5M | $227.0M | $93.0M | $66.2M | $49.6M | |
| Intangible Assets And Goodwill | $1.61B | $790.4M | $804.1M | $158.5M | $202.4M | $163.5M | $89.4M | $88.0M | $83.5M | |
| Adjustments For Increase Decrease In Trade Payables Other Liabilities Contract Liabilities And Provisions | -$723.8M | $758.4M | $118.9M | $85.7M | $1.52B | $204.6M | -$80.6M | -$21.1M | ||
| Noncurrent Contract Liabilities | $88.0M | $183.0M | $398.5M | $48.4M | $9.0M | $71.9M | $97.1M | $205.6M | ||
| Current Contract Liabilities | $754.9M | $294.9M | $353.3M | $77.1M | $186.1M | $299.6M | $93.6M | $66.0M | ||
| Rightofuse Assets | $210.2M | $248.1M | $214.4M | $211.9M | $197.9M | $99.0M | $55.0M | $49.8M | ||
| Purchase Of Intangible Assets And Right Of Use Assets Classified As Investing Activities | $573.9M | $165.8M | $455.4M | $34.1M | $26.5M | $19.4M | $32.5M | |||
| Other Current Financial Liabilities | $351.7M | $1.44B | $415.2M | $785.1M | $1.19B | $74.1M | $10.4M | $8.3M | ||
| Other Current Financial Assets | $7.20B | $7.02B | $4.89B | $189.4M | $381.6M | $137.2M | $1.7M | $336.0K | ||
| Noncurrent Liabilities | $622.1M | $595.4M | $689.9M | $272.9M | $455.5M | $340.8M | $166.0M | $259.9M | ||
| Noncurrent Assets | $5.84B | $3.73B | $3.48B | $1.36B | $758.5M | $651.7M | $237.5M | $204.0M | ||
| Liabilities | $2.76B | $3.12B | $2.76B | $3.22B | $3.94B | $946.8M | $304.2M | $386.0M | ||
| Gains Losses On Financial Liabilities At Fair Value Through Profit Or Loss | $10.4M | -$4.6M | -$175.5M | $241.0M | -$57.3M | $0.00 | $0.00 | |||
| Equity And Liabilities | $21.99B | $22.53B | $23.01B | $23.28B | $15.83B | $2.32B | $797.6M | $653.0M | ||
| Current Tax Liabilities Current | $65.6M | $4.5M | $525.5M | $595.9M | $1.57B | $0.00 | $150.0K | $297.0K | ||
| Current Tax Assets Current | $52.6M | $50.0M | $179.1M | $400.0K | $400.0K | $900.0K | $756.0K | $891.0K | ||
| Current Liabilities | $2.14B | $2.52B | $2.07B | $2.95B | $3.48B | $606.0M | $138.1M | $126.1M | ||
| Current Assets | $16.15B | $18.80B | $19.53B | $21.92B | $15.07B | $1.67B | $560.2M | $449.0M | ||
| Assets | $21.99B | $22.53B | $23.01B | $23.28B | $15.83B | $2.32B | $797.6M | $653.0M | ||
| Adjustments For Decrease Increase In Trade Accounts Receivable Contract Assets And Other Assets | $1.08B | $387.7M | $5.37B | $4.37B | -$11.81B | -$247.9M | $2.9M | |||
| Other Noncurrent Financial Assets | $2.55B | $1.25B | $1.18B | $80.2M | $21.3M | $0.00 | $18.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Payments Of Lease Liabilities Classified As Financing Activities | $39.6M | $43.6M | $40.3M | $41.1M | $14.1M | $12.7M | $3.1M | $2.1M | $1.6M |
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | -$2.07B | -$1.92B | -$2.36B | $12.12B | $417.8M | $736.4M | $107.6M | $239.8M | -$106.8M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$27.0M | $14.8M | -$14.5M | $60.1M | $64.7M | -$45.3M | $0.00 | -$459.0K | -$24.8M |
| Proceeds From Borrowings Classified As Financing Activities | $6.7M | $0.00 | $300.0K | $800.0K | $0.00 | $156.0M | $11.0M | $5.6M | |
| Proceeds From Issuing Shares | 0.00 | 0.00 | 110.5M | 160.9M | 753.0M | 375.4M | 361.7M | ||
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $600.0K | $3.4M | $1.2M | $0.00 | $705.0K | $5.2M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $-4.70 | $-2.77 | $3.83 | $37.77 | $39.63 | $0.06 | $-0.85 |
| Basic Earnings Loss Per Share | $-4.70 | $-2.77 | $3.87 | $38.78 | $42.18 | $0.06 | $-0.85 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Miscellaneous Other Operating Income | $184.6M | $140.6M | $105.0M | $815.3M | $598.4M | $250.5M | $2.7M | $5.4M | $2.3M |
| Miscellaneous Other Operating Expense | $1.09B | $811.5M | $293.0M | $410.0M | $103.4M | $2.4M | $700.0K | $720.0K | $288.0K |
| Interest Received Classified As Operating Activities | $337.0M | $474.9M | $258.2M | $29.3M | $1.2M | $1.4M | $1.3M | $2.0M | $2.1M |
| Interest Paid Classified As Operating Activities | $11.0M | $13.5M | $5.4M | $21.5M | $12.2M | $3.6M | $2.0M | $1.8M | $729.0K |
| Increase Decrease Through Sharebased Payment Transactions | $65.0M | -$66.4M | $15.4M | -$681.3M | $59.8M | $32.0M | $30.2M | $7.6M | $5.9M |
| Finance Income | $423.9M | $664.0M | $519.6M | $330.3M | $67.7M | $1.6M | $4.1M | $8.0M | $2.1M |
| Finance Costs | $69.8M | $27.4M | $23.9M | $18.9M | $305.1M | $65.0M | $2.0M | $48.0K | $26.0M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -$6.6M | -$109.5M | -$298.0M | $625.5M | -$387.5M | $41.3M | $100.0K | $459.0K | $24.8M |
| Adjustments For Sharebased Payments | $106.2M | $100.9M | $51.4M | $108.6M | $93.9M | $32.1M | $30.2M | $7.6M | $5.9M |
| Adjustments For Finance Income | $423.9M | $648.5M | $519.6M | $265.3M | $1.5M | $1.6M | $1.8M | $2.0M | $2.1M |
| Adjustments For Finance Costs | $21.4M | $27.4M | $7.9M | $18.9M | $305.2M | $22.3M | $2.0M | $48.0K | $53.0K |
| Adjustments For Depreciation And Amortisation Expense | $382.8M | $298.0M | $183.4M | $123.3M | $75.2M | $38.7M | $33.9M | $22.0M | $10.5M |
| Adjustments For Decrease Increase In Inventories | $177.9M | $74.5M | $81.9M | $62.9M | -$438.4M | -$49.8M | -$5.8M | -$1.3M | -$574.0K |
| Repayments Of Borrowings Classified As Financing Activities | $18.0M | $2.3M | $100.0K | $18.8M | $52.6M | $1.6M | $0.00 | ||
| Adjustments For Movements In Government Grants | -$63.0M | -$31.5M | $2.4M | $300.0K | -$89.0M | $92.0M | $0.00 | ||
| Other Reserves | -$1.46B | -$1.33B | -$984.6M | -$848.9M | $93.9M | $25.4M | $4.8M | -$25.5M | |
| Issued Capital | $259.0M | $248.6M | $248.6M | $248.6M | $246.3M | $246.3M | $232.3M | $193.3M | |
| Inventories | $110.7M | $283.3M | $357.7M | $439.6M | $502.5M | $64.1M | $11.7M | $5.8M | |
| Capital Reserve | $2.47B | $1.40B | $1.23B | $1.83B | $1.67B | $1.51B | $686.7M | $344.1M | |
| Treasury Shares | 7.7M | 8.6M | 10.8M | 5.3M | 3.8M | 4.8M | 5.5M | ||
| Other Adjustments For Noncash Items | $585.4M | $0.00 | $0.00 | $0.00 | -$2.2M | $1.7M | $0.00 | ||
| Current Provisions | $145.3M | $144.8M | $269.3M | $367.2M | $110.2M | $900.0K | $762.0K | $710.0K | |
| Share Issue Related Cost | $100.0K | $2.7M | $33.2M | $16.6M |
Most recent annual filing with the SEC: March 10, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.